Michael Law

Mike

Director, Centre for Health Services and Policy Research
Canada Research Chair in Access to Medicines
Professor, UBC School of Population and Public Health

michael.law@ubc.ca
(604) 822-3514


Profile

Dr. Michael Law holds the Canada Research Chair in Access to Medicines, and is an Associate Professor in the Centre for Health Services and Policy Research, School of Population and Public Health, at the University of British Columbia.

Michael’s research program focuses on pharmaceutical policy. His work focuses on access to and the use of prescription drugs, including the affordability of prescription drugs, private drug insurance, generic drug pricing, and the impact of pharmacist prescribing. His research program has attracted more than $2.5 million in research funding, including 4 operating grants from CIHR as principal investigator.

He has been published in leading medical journals, including BMJ, Archives of Internal Medicine, and CMAJ. This work has been featured in news media such as New Scientist, Forbes, the Globe & Mail, and USA Today. He has also authored commentaries that have appeared in the Toronto Star and Vancouver Sun. His research has had a major impact on generic drug pricing in Canada, leading to policy changes that have saved governments the country more than $100 million every year.

Since his appointment at UBC he has received several notable awards, including a Distinguished Achievement Award from the UBC Faculty of Medicine (2012), the Labelle Lectureship at McMaster University, the 2011 Paper of the Year Award from the Canadian Institute for Health Services and Policy Research, a Canadian Institutes of Health Research New Investigator Award, and a Michael Smith Foundation for Health Research Scholar Award.

In 2015, he taught one of UBC’s first edX.org Professional Education courses on Interrupted Time Series Analysis.

Prior to joining UBC, he completed a PhD in Health Policy at Harvard University and a post-doctoral fellowship at Harvard Medical School, where he trained in research methods and statistics. He has also completed an MSc from the London School of Economics, and worked as a research associate at the University of Auckland, New Zealand.

Education

PhD, Health Policy, Harvard University, 2008
MSc, Health Population and Society, London School of Economics, 2002
BA&Sc, Arts & Sciences Program, McMaster University, 2001

Research Interests

  • Pharmaceutical policy
  • Direct-to-consumer advertising of prescription drugs
  • Medication adherence and health outcomes

Current Projects

  • Cost-related nonadherence to prescription drugs: A multi-method study
  • Impact of physician detailing and sampling for generic atorvastatin

Affiliations and Awards

  • Career Investigator Scholar Award, Michael Smith Foundation for Health Research, 2012-2020
  • New Investigator Award, CIHR, 2010-2015

Current Graduate Students

  • Shania Au, MSc Student, School of Population and Public Health
  • Talshyn Bolatova, MSc Student, School of Population and Public Health
  • Celestin Hategeka, PhD Student, School of Population and Public Health
  • Richard Musoke, PhD Student, School of Population and Public Health
  • Marie Paul Nisingizwe, PhD Student, School of Population and Public Health
  • Hinda Ruton, PhD Student, School of Population and Public Health
  • Seraphine Zeitouny, MSc Student, School of Population and Public Health

Currently Recruiting Graduate Students Interested in

  • Pharmaceutical policy
  • Access to medicines
  • Observational study design

Courses Currently Taught


Recent Publications

Innes GD, Scheuermeyer FX, McRae AD, Law MR, Teichman JMH, Grafstein E, Andruchow JE. Which Patients Should Have Early Surgical Intervention for Acute Ureteric Colic. J Urol. 2020 Jul 27;101097JU0000000000001318. Online ahead of print. Read more

Palmer K, Law M, Worthington H. Private Parts? Finding the balance of public and private in health care: Conference summary. Vancouver (BC): UBC Centre for Health Services and Policy Research; 2020. Read more

Laba TL, Cheng L, Worthington HC, McGrail KM, Chan FKI, Mamdani M, Law MR. What happens to drug use and expenditure when cost sharing is completely removed? Evidence from a Canadian provincial public drug plan. Health Policy. 2020 May 23:S0168-8510(18)30587-6. Online ahead of print. Read more

Kitchen SA, McGrail K, Wickham ME, Law MR, Hohl CM. Emergency department-based medication review on outpatient health services utilization: interrupted time series. BMC Health Serv Res. 2020 Mar 26;20(1):254. Read more

Laba TL, Cheng L, Kolhatkar A, Law MR. Cost-related nonadherence to medicines in people with multiple chronic conditions. Research in Social and Administrative Pharmacy;16(3):415-421.Read more

Hedden L, Munro S, McGrail KM, Law MR, Bourgeault IL, Barer ML. Is attending birth dying out? Trends in obstetric care provision among primary care physicians in British Columbia. Can Fam Physician. 2019 Dec;65(12):901-909. Read more

Law MR, Chan FKI, Harrison M, Worthington HC. Impact of brand drug discount cards on private insurer, government and patient expenditures. CMAJ. 2019 Nov 11;191(45):E1237-E1241. Read more

Bolatova T, Law MR. Income-related disparities in private prescription drug coverage in Canada. CMAJ Open. 2019 Oct 11;7(4):E618-E623. Read more

Persaud N, Bedard M, Boozary AS, Glazier RH, Gomes T, Hwang SW, Jüni P, Law MR, Mamdani MM, Manns BJ, Martin D, Morgan SG, Oh PI, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Laupacis A; Carefully Selected and Easily Accessible at No Charge Medicines (CLEAN Meds) Study Team. Effect on Treatment Adherence of Distributing Essential Medicines at No Charge: The CLEAN Meds Randomized Clinical Trial. JAMA Intern Med. 2019 Oct 7. [Epub ahead of print] Read more

Hung YW, Law MR, Cheng L, Abramowitz S, Alcayna-Stevens L, Lurton G, Mayaka SM, Olekhnovitch R, Kyomba G, Ruton H, Ramazani SY, Grepin K. Impact of a Free Health Care Policy in the Democratic Republic of the Congo During an Ebola Outbreak: An Interrupted Time-Series Analysis (July 14, 2019). Available at SSRN. Read more

Cassels A, Law MR. The impact of the introduction of a formulary into a large Canadian private drug plan: an interrupted time-series analysis. CMAJ Open. 2019 Jul 18;7(3):E472-E477. Read more

Laba TL, Cheng L, Kolhatkar A, Law MR. Cost-related nonadherence to medicines in people with multiple chronic conditions. Res Social Adm Pharm. 2019 Jun 20. [Epub ahead of print] Read more

McKay R, Patrick DM, McGrail K, Law MR. Antibiotic prescribing for pediatric respiratory infections: What explains a large variation among physicians? Can Fam Physician. 2019 Jun;65(6):e278-e291. Read more

McGrail K, Ahuja M, Huang X, Law M, Wong S, Harrison M, McGregor M, Berg S, Bryan S, Mitton C. An Evaluation of the Accelerated Integrated Primary and Community Care Initiatives. Vancouver, BC: UBC Centre for Health Services and Policy Research; April 2019. Read more

Rosman SL, Karangwa V, Law M, Monuteaux MC, Briscoe CD, McCall N. Provisional Validation of a Pediatric Early Warning Score for Resource-Limited Settings. Pediatrics. 2019 Apr 16. [Epub ahead of print] Read more

Older publications